Su-Yeon Nam
President at GI INNOVATION, INC.
Net worth: 12 M $ as of 29/04/2024
Profile
Su-Yeon Nam is currently the Chief Executive Officer at Ints Bio Co. Ltd.
and the Co-President, Director & Head-Overseas Sales at GI Innovation, Inc. Previously, Dr. Nam worked as the Head-Medical Director at Bristol Myers Squibb Co. in 2011, as the MD & Head-Chung Ang Research Institute at Yuhan Corp.
from 2014 to 2016, and as the Head-Medical Department at Bristol-Myers Squibb (Singapore) Pte Ltd.
Dr. Nam obtained a doctorate degree from Yonsei University in 2001.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GI INNOVATION, INC.
2.80% | 18/04/2024 | 1,235,122 ( 2.80% ) | 12 M $ | 29/04/2024 |
Su-Yeon Nam active positions
| Companies | Position | Start |
|---|---|---|
| GI INNOVATION, INC. | President | 30/11/2018 |
| Ints Bio Co. Ltd. | Chief Executive Officer | - |
Former positions of Su-Yeon Nam
| Companies | Position | End |
|---|---|---|
| YUHAN CORPORATION | Chief Tech/Sci/R&D Officer | 30/12/2016 |
| Bristol-Myers Squibb (Singapore) Pte Ltd. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of Su-Yeon Nam
| Yonsei University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GI INNOVATION, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| YUHAN CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
| Ints Bio Co. Ltd. | |
| Bristol-Myers Squibb (Singapore) Pte Ltd. |
- Stock Market
- Insiders
- Su-Yeon Nam
